Skip to main content
Fig. 4 | BMC Endocrine Disorders

Fig. 4

From: The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas

Fig. 4

Comparison of the effects of bromocriptine on NF-κB p65, Bcl2 and Bax in GH3 cells and MMQ cells. a, b The apoptosis rate of GH3 and MMQ cells treated with bromocriptine (12.5 μM, 25 μM, 50 μM) for 48 hours was detected by Annexin V-FITC and PI double staining.**p < 0.01 vs. Control,***p < 0.001 vs. Control, ****p < 0.0001 vs. control, (n = 3). c, d Western blot analysis of NF-κB p65, Bcl2 and Bax protein expression after bromocriptine treatment of GH3 cells and MMQ cells for 48 h.**p < 0.01 vs. 0 μM,***p < 0.001 vs. 0 μM,****p < 0.0001 vs. 0 μM, (n = 3)

Back to article page